United States: The U.S. Government's Recent Efforts To Ban Pharmaceutical Executives From The Industry Without Due Process

Earlier this month, as part of the Obama Administration's effort to make the case that it will pursue individual high-level executives and CEOs in addition to the companies they run, the Office of the Inspector General, Department of Health and Human Services ("HHS-OIG") informed the Chairman, CEO and President of Forest Laboratories Inc. ("Forest Labs") that it intends to exclude him from doing business with the federal government. Such an exclusion of Forest Labs' top executive could prevent Forest Labs from selling its drugs in connection with government programs such as Medicare, Medicaid and the Veterans Administration, which could amount to a corporate death sentence, unless the company drops the executive. One would think that the executive must have been found guilty of criminal activity, or found liable for misconduct in a civil lawsuit, but that is not the case. The executive has never been accused of or charged with any wrongdoing.

According to a press release by Forest Labs,1 this potential action stems from a global settlement in September 2010 with the U.S. Department of Justice ("DOJ"), as part of which the company, among other things, pled guilty to two no-intent, strict liability misdemeanor violations of the federal Food, Drug and Cosmetic Act (FDCA) relating to conduct that occurred almost a decade ago involving the distribution and marketing of Levothroid and Celexa. Forest Labs' settlement with the DOJ included no acknowledgment of wrongdoing by the now targeted executive.2

The HHS-OIG has not yet made a final decision concerning its potential action against the Forest Labs executive; however, the agency is widely expected to act on its threat to invoke its permissive exclusion authority under Section 1128(b)(15) of the Social Security Act.3 The permissive exclusion authority permits the HHS-OIG to exclude certain entities and individuals, including officers or managing agents of a company convicted of certain offenses, from participation in any federal health care program. While owners of the entity may be excluded only if they knew or should have known about the conduct that led to the sanction, officers or managing employees may be excluded based solely on their position within the entity, whether or not they knew or should have known about the bad conduct.4 In October 2010, the HHS-OIG issued a notice which provided guidance regarding the factors that it would consider in deciding whether to exclude individuals.5 The factors that the HHSOIG will consider include the circumstances of the misconduct, seriousness of the violations, the individual's role within the entity and the individual's response to the misconduct. The action against the Forest Labs executive, if taken, represents an aggressive use of sanctions to exclude an executive who has not been personally accused of or charged with any wrongdoing.

Despite the HHS-OIG's seemingly broad power to exclude, in prior HHS-OIG permissive exclusion actions against pharmaceutical executives, criminal or civil charges against the individuals themselves have preceded or closely followed such actions. For example, in 2007, three Purdue Frederick Co. executives who had previously pled guilty to criminal misdemeanor misbranding charges were excluded by the HHS-OIG.6 More recently, in November 2010, Marc Hermelin, an owner/operator of KV Pharmaceutical, was excluded by the HHS-OIG prior to civil or criminal charges, but such charges were clearly contemplated at the time, and Hermelin pled guilty to two criminal misdemeanor violations shortly thereafter.7

The HHS-OIG's stated intent to exclude executives against whom the government has insufficient evidence to charge criminally or civilly is a troubling development, because it provides little meaningful opportunity for the individuals to defend against the exclusion. It is the HHS-OIG's view that there is no opportunity for administrative or judicial review, although this view will likely be tested in courts. Without an effective way to challenge the HHS-OIG's discretionary exclusions, the HHS-OIG has a powerful tool that is susceptible to abuse.

Moreover, the trend toward more aggressive use of the exclusion tool could impact companies outside the health care industry as well. For instance, the exclusion might also impact companies which do business with the Defense Department or the Environmental Protection Agency, as these entities have exclusion powers similar to the HHS-OIG permissive exclusion authority.

When dealing with civil and criminal investigations and cases, it is critical to develop a comprehensive strategy at the outset which addresses all risks, including new elevated risks such as the exclusion tool.

Footnotes

1. Forest Laboratories, Forest Laboratories Chairman and CEO to Challenge "Unwarranted and Unprecedented" Potential Action to Exclude Him from Federal Healthcare Programs (April 13, 2011), available at http://www.frx.com/news/PressRelease.aspx?ID=1550242 (last visited on Apr. 26, 2011).

2. See supra note 1.

3. The Section states, "The Secretary may exclude the following individuals and entities from participation in any Federal health care program... Any individual—(i) who has a direct or indirect ownership or control interest in a sanctioned entity and who knows or should know of the action constituting the basis for the conviction or exclusion described in subparagraph (B); or (ii) who is an officer or managing employee of such an entity." (emphasis added)

4. "With respect to officers and managing employees, the statute includes no knowledge element. Therefore, OIG has the authority to exclude every officer and managing employee of a sanctioned entity." Id.

5. Office of Inspector General, Guidance for Implementing Permissive Exclusion Authority Under Section 1128(b)(15) of the Social Security Act (Oct. 19, 2010), available at http://oig.hhs.gov/fraud/exclusions/files/permissive_excl_under_1128b15_10192010.pdf (last visited on Apr. 26, 2011).

6. Office of Inspector General, Administrative Law Judge Upholds HHS-OIG Exclusions Imposed Against Responsible Corporate Officers in OxyContin Case, Office of Inspector General News (January 23, 2009), available at http://oig.hhs.gov/publications/docs/press/2009/hhs_oig_press_01232009.pdf (last visited on Apr. 26, 2011).

7. Harris, Andrew and Joe Whittington, Ex-KV Pharmaceutical CEO Hermelin Pleads Guilty to Drug Label Law Breach, Bloomberg.com (March 10, 2011), available at http://www.bloomberg.com/news/2011-03-10/ex-kv-pharmaceutical-ceo-hermelin-pleads-guilty-to-drug-label-law-breach.html (last visited on Apr. 26, 2011).

The content of this article does not constitute legal advice and should not be relied on in that way. Specific advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Kenneth M. Breen
 
In association with
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert
Email Address
Company Name
Password
Confirm Password
Mondaq Topics -- Select your Interests
Accounting and Audit
Anti-trust/Competition Law
Consumer Protection
Corporate/Commercial Law
Criminal Law
Employment and HR
Energy and Natural Resources
Environment
Family and Matrimonial
Finance and Banking
Food, Drugs, Healthcare, Life Sciences
Government, Public Sector
Immigration
Insolvency/Bankruptcy, Re-structuring
Insurance
Intellectual Property
International Law
Litigation, Mediation & Arbitration
Media, Telecoms, IT, Entertainment
Privacy
Real Estate and Construction
Strategy
Tax
Transport
Wealth Management
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.